PolarSeal Sets Sight on Manufacturing Arm in the USA

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

PolarSeal®, a prominent provider of medical device contract manufacturing and adaptable material conversion, is excited to announce its strategic manufacturing expansion plans into the United States, targeting the dynamic Med-Tech market and the burgeoning Medical Manufacturing sectors.

SURREY, UK / ACCESSWIRE / November 2, 2023 / With a proven track record of excellence and innovation in the medical device industry, PolarSeal® is poised to bring its cutting-edge capabilities to a new market, further solidifying its position as a global leader in the field.

PolarSeal Press Release
PolarSeal® Sets Sight on Manufacturing Arm in the USA

The decision to establish a manufacturing presence in the USA comes as part of PolarSeal®’s commitment to meeting the evolving needs of its clients and partners. The move reflects the company’s dedication to providing high-quality, reliable, and innovative solutions that contribute to the advancement of medical device technologies.

Renowned for its extensive experience, PolarSeal® has forged deep collaborations with world-leading medical device companies and healthcare providers. By expanding into the USA, PolarSeal® aims to provide local support to its existing partners while also forging new connections within the American medical device industry.

“We are thrilled to embark on this new chapter of growth and expansion,” said Matthew Rich, General Manager at PolarSeal®. “Our presence in the USA will enable us to better serve our clients and partners, offering them a direct access point to our state-of-the-art manufacturing capabilities and industry-leading expertise.”

PolarSeal® has garnered a distinguished reputation for excellence through its unwavering dedication to quality, innovation, and adherence to regulatory standards. As part of its strategic vision, the company is set to enhance the American medical device industry by establishing a manufacturing presence in the USA. Progress is already underway, with PolarSeal® actively installing equipment and facilities throughout 2024, paving the way for full-scale manufacturing operations to commence in 2025.

As the expansion unfolds, PolarSeal® is excited to bring its extensive capabilities, including cleanroom manufacturing, material selection expertise, and medical adhesive solutions, to the American market. This move not only reinforces PolarSeal®’s global presence but also underlines its dedication to driving advancements in medical manufacturing for improved patient care.

About PolarSeal

PolarSeal is a leading contract manufacturer and flexible material converter in the medical device industry. With a focus on innovation, quality, and collaborative partnerships, PolarSeal® provides solutions for world-leading medical device companies and healthcare providers. The company’s expertise spans cleanroom manufacturing, material selection, medical adhesives, and more.

For more information about PolarSeal, visit the company’s website at https://polarsealmedical.com.

Contact Information:

Shaun Kemp
Marketing Manager
inquiries@polarsealusa.com
+44 1252 726 000

SOURCE: PolarSeal

View source version on accesswire.com:
https://www.accesswire.com/798033/polarseal-sets-sight-on-manufacturing-arm-in-the-usa

Staff

Recent Posts

FinThrive Introduces Agentic AI at HFMA 2025 to Help Customers Transform Healthcare Revenue Cycle Management Performance

Company to also highlight advancements in denials and underpayments management and speak to the measurable…

3 hours ago

FinThrive Debuts Denials and Underpayments Analyzer, a Unified Solution for Denials and Underpayments, at HFMA 2025

Next generation analyzer helps hospitals protect revenue before it's lost by delivering timely end-to-end visibility…

3 hours ago

Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine

Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed mean weight reduction…

6 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project as Federal Support for Blockchain Grows

Dr. Anosh Ahmed repurposes West Side warehouse into blockchain innovation center, targeting 250+ jobs and…

6 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project Amid National Pro-Crypto Policy Shift

Dr. Anosh Ahmed converts vacant West Side warehouse into blockchain innovation hub, creating 250+ jobs…

6 hours ago

BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

Treatment with apelin receptor agonist enhanced glycemic control and demonstrated cardioprotective effects, with additive benefits…

6 hours ago